Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$8,611,875
in 1 filing

Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. DeLuca Richard R. −$8.6M EVP&Pres, Merck Animal Heallth sold 34% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-29 Rothman Paul Director Grant or award · Phantom Stock +1,853.1 $118.72 $220K 34,944.94
2025-05-30 Rothman Paul Director Grant or award · Phantom Stock +2,863.09 $76.84 $220K 31,990.8
2024-05-31 Rothman Paul Director Grant or award · Phantom Stock +1,752.43 $125.54 $220K 28,233.61
2023-05-26 Rothman Paul Director Grant or award · Phantom Stock +1,980.73 $111.07 $220K 25,797.52
2022-05-27 Rothman Paul Director Grant or award · Phantom Stock +2,363.56 $93.08 $220K 23,152.02
2021-05-28 Rothman Paul Director Grant or award · Phantom Stock +2,635.39 $75.89 $200K 19,522.48
2020-05-29 Rothman Paul Director Grant or award · Phantom Stock +2,477.7 $80.72 $200K 16,361.59

Page 1 of 1 · 7 trades